Medclair AB (NGM:MCLR) 3-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medclair AB 3-Year EBITDA Growth Rate?

Medclair AB's EBITDA per Share for the three months ended in Mar. 2024 was kr0.02.

During the past 12 months, Medclair AB's average EBITDA Per Share Growth Rate was 277.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Medclair AB was 69.40% per year. The lowest was 2.80% per year. And the median was 34.25% per year.

Competitive Comparison of Medclair AB's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Medclair AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medclair AB's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Medclair AB's 3-Year EBITDA Growth Rate falls into.

Medclair AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Medclair AB (NGM:MCLR) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Medclair AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Medclair AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medclair AB (NGM:MCLR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Box 3113, Stockholm, SWE, 103 62

Website

https://www.medclair.com

Medclair Invest AB is a research and development company with leading-edge expertise in measurement, collection and destruction of Nitrous Oxide. The customers are found in a number of industries such as Obstetrics, Pediatrics, Emergency departments and Dental Care facilities. The business is operational on a global scale.

Medclair AB (NGM:MCLR) Headlines

No Headlines